Conor Hale is the senior editor of Fierce Medtech, which covers the development of innovative medical devices, artificial intelligence programs, diagnostic tests and research tools alongside the work of its sibling publications Fierce Biotech, Fierce Pharma and Fierce Healthcare. Based in the Washington, D.C. area, he has been writing for more than 10 years about the biopharma and device industries’ intersections with the federal government—including the FDA’s regulatory sphere, the NIH’s research enterprises and legislation from Capitol Hill—as well as news in venture capital and mergers & acquisitions. He graduated from St. Bonaventure University’s Jandoli School of Journalism.